Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection.

MLA

Augello, Matteo, et al. “Six-Month Immune Responses to MRNA-1273 Vaccine in Combination Antiretroviral Therapy Treated Late Presenter People with HIV According to Previous SARS-CoV-2 Infection.” AIDS (London, England), vol. 37, no. 10, Aug. 2023, pp. 1503–17. EBSCOhost, https://doi.org/10.1097/QAD.0000000000003585.

APA

Augello, M., Bono, V., Rovito, R., Tincati, C., d’Arminio Monforte, A., & Marchetti, G. (2023). Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection. AIDS (London, England), 37(10), 1503–1517. https://doi.org/10.1097/QAD.0000000000003585

Chicago

Augello, Matteo, Valeria Bono, Roberta Rovito, Camilla Tincati, Antonella d’Arminio Monforte, and Giulia Marchetti. 2023. “Six-Month Immune Responses to MRNA-1273 Vaccine in Combination Antiretroviral Therapy Treated Late Presenter People with HIV According to Previous SARS-CoV-2 Infection.” AIDS (London, England) 37 (10): 1503–17. doi:10.1097/QAD.0000000000003585.